Anti-factor Xa levels in obese patients receiving enoxaparin for treatment and prophylaxis indications

Linda Tahaineh,1 Sahar M Edaily,1 Shadi F Gharaibeh2 1Department of Clinical Pharmacy, Faculty of Pharmacy, Jordan University of Science and Technology (JUST), Irbid, Jordan; 2Department of Pharmaceutical Sciences, Faculty of Pharmacy, Jerash University, Jerash, Jordan Objectives: To evaluate the de...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tahaineh L, Edaily SM, Gharaibeh SF
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2018
Materias:
Acceso en línea:https://doaj.org/article/df87d9ab82574242b6cbd410b1584d3a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!